Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine

Fig. 2

Clinical outcomes of 144 LSCC patients and expression of 7 target proteins. Kaplan-Meier analyses of overall survival (OS) and disease-free survival (DFS) were performed for 144 patients classified into high- and low-expression groups of STXBP4, TP63 (ΔNp63), p53, VEGFR2, TUBB3, STMN1, and PD-; X axis, survival time expressed in months

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us